Publications by authors named "Keith P Falsetta"
Article Synopsis
- The study investigates how COVID-19 affects the treatment of diabetic ketoacidosis (DKA) in patients with type 2 diabetes by comparing the insulin doses needed for recovery between two groups: those with COVID-19 and those without.
- Results showed that COVID-19 patients required a significantly higher cumulative insulin dose (190.3 units) and took longer to resolve DKA (35.9 hours) compared to non-COVID patients (116.4 units and 15.6 hours, respectively).
- The findings suggest that patients with COVID-19 have more severe DKA, evident through increased insulin infusion rates and higher doses needed based on body weight, indicating a greater challenge in managing DKA in these
